3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
277
Lung Neoplasms
177
Small Cell Lung Carcinoma
51
Colorectal Neoplasms
49
Neoplasms
35
Ovarian Neoplasms
34
Melanoma
31
Pancreatic Neoplasms
29
Neoplasm Metastasis
25
Breast Neoplasms
25
Stomach Neoplasms
24
Squamous Cell Carcinoma of Head and Neck
22
Carcinoma, Renal Cell
21
Urinary Bladder Neoplasms
19
Triple Negative Breast Neoplasms
18
Head and Neck Neoplasms
18
Esophageal Neoplasms
18
Endometrial Neoplasms
18
Prostatic Neoplasms
16
Mesothelioma
15
Colonic Neoplasms
14
Carcinoma, Hepatocellular
14
Uterine Cervical Neoplasms
13
Sarcoma
11
Mesothelioma, Malignant
11
Adenocarcinoma of Lung
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Lung Diseases
10
Cholangiocarcinoma
9
Carcinoma, Transitional Cell
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cachexia
×
Thoracic
×
30 days
×
Clear all
NCT05546476
2026-06-03
PROACC-1
Pfizer
Phase 2
Completed
187 enrolled
24 charts